Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
AI bioprocess simulation and downstream manufacturing optimisation software
New Wave Biotech is a software company developing AI-powered tools for bioprocess simulation and downstream manufacturing optimisation. Its Bioprocess Foresight platform combines mechanistic process models with machine learning to predict product yield, process costs and environmental impacts. Scientists and engineers…
ENTECH platform for cell perturbation and AI target discovery
Aparna Bio develops technologies for generating biologically relevant cell-perturbation data to support drug target discovery. Its ENTECH platform is being engineered to deliver experimental perturbation reagents into primary human cells and other disease-relevant models, where conventional delivery methods can be…
AI-guided personalised mRNA cancer vaccine development
Genevation is a biotechnology company developing personalised mRNA cancer vaccines using AI-assisted tumour neoantigen identification. Its platform analyses tumour sequencing data to select patient-specific targets and combines computational vaccine design with cell-free RNA manufacturing. The company reports…
AI-powered point-of-care genomic sequencing for hospitals and clinics
SiGenex Oxford is the UK research and development arm of SiGenex, developing an AI-powered, decentralised platform for point-of-care genomic and multi-omic diagnostics. The technology combines digital microfluidics with automated next-generation sequencing and AI-driven bioinformatics to deliver genomic results…
Infrared spectroscopy blood test for early multi-cancer detection
Dxcover is a clinical-stage biotechnology company developing a blood-based multi-cancer early detection test. Its platform applies infrared spectroscopy to a dried blood spot to capture a pan-omic biological signature spanning proteins, lipids, metabolites, and nucleic acids simultaneously. Machine learning algorithms…
AI-guided plant biosynthesis platform for novel therapeutic compounds
HotHouse Therapeutics is a drug discovery platform company that engineers plants as sustainable biofactories for pharmaceutical compound production. Using AI to design and optimise biosynthetic pathways, it produces both natural and new-to-nature molecules via transient and stable plant expression systems capable of…
AI-designed serum-free cell culture media for biomanufacturing
Multus Biotechnology is a UK developer and manufacturer of serum-free, animal-component-free cell culture media and growth media ingredients. The company combines machine learning and high-throughput robotic automation to design and optimise custom media formulations for specific cell types across cultivated meat,…
RNA sequencing liquid biopsy for cardiovascular and complex disease screening
MultiplAI Health is a Cambridge biotech developing a whole-blood RNA sequencing test for early screening of cardiovascular and other complex diseases. Its platform combines transcriptomic profiling of blood samples with a patented data transformation process and proprietary deep learning algorithms to generate…
AI-driven T-cell receptor discovery platform for solid tumour immunotherapies
Exogene is an Oxford biotech developing TCR-based immunotherapies for solid tumours. Its platform integrates generative AI, biophysical simulation, and high-throughput TCR-antigen screening to identify rare, high-affinity cancer-specific T-cell receptors from patient tumour samples. The company develops TCR-T cell…
Clinical skin microbiome testing and multi-omic ingredient analysis platform
Sequential Skin is a biotechnology company providing non-invasive clinical microbiome testing and multi-omic analysis services to the personal care and pharmaceutical industries. Using patch-based sampling and next-generation sequencing, the company quantifies how ingredients and formulations affect the skin…
Deep learning platform for small molecule drug discovery
CHARM Therapeutics is a clinical-stage biotechnology company applying 3D deep learning to small molecule drug discovery. Its proprietary platform uses protein-ligand co-folding algorithms to predict binding interactions and identify candidates against difficult-to-drug targets. CHARM's pipeline focuses primarily on…
Omics interpretation and mechanism-of-action analysis for agricultural biotechnology
TraitSeq is an agricultural bioinformatics company analysing transcriptomic and other omics datasets to explain biological responses to crop inputs. Its platform combines statistical analysis with species-specific knowledge graphs, published literature and AI-assisted interpretation to identify molecular pathways,…
Pharmacogenomic platform for personalised hormone therapy prescribing
Dama Health is a clinical decision-support software company focused on personalised prescribing of hormone therapies in women's health. Its platform collects patient health, lifestyle, and genetic data and uses an AI-driven recommendation engine to match patients to appropriate hormone therapies and contraceptives.…
ML-enabled nanoparticle delivery platform for targeted therapeutics
Vector Bioscience is a University of Cambridge spin-out developing a machine learning-enabled drug delivery platform based on metal-organic framework nanoparticles. The technology provides cargo-agnostic, targeted delivery of oligonucleotides and small molecules with controlled release, initially focused on…
AI-driven automated flow chemistry platform for chemical process development
SOLVE Chemistry is a contract research and technology company providing AI-powered process development services to pharmaceutical, agrochemical, and specialty chemical manufacturers. Its automated flow chemistry laboratory collects dense kinetic datasets on chemical reactions at speed, training proprietary machine…
Proteomics and AI liquid biopsy for early lung cancer detection
Oxford Cancer Analytics is a biotechnology company developing blood-based diagnostic tests for early cancer detection using high-throughput circulating proteome analysis and machine learning. Its platform identifies protein biomarker signatures from blood samples to support clinical decision-making in lung disease,…
Integrated outsourced drug discovery and development platform
RxCelerate is a contract research organisation providing fully integrated drug discovery and development services to pharmaceutical and biotech companies. Based at Babraham Research Campus, the company offers end-to-end programme delivery spanning computational design, antibody discovery, medicinal chemistry, in vitro…
AI-driven drug discovery targeting necrosis and age-related disease
LinkGevity is a preclinical-stage biotechnology company developing anti-necrotic therapeutics for age-related and degenerative diseases. Founded in 2023 and based at Babraham Research Campus, the company's proprietary Blueprint Theory of Ageing identifies necrosis as a key driver of biological decline, informing its…
AI software for embryo and sperm selection in assisted reproductive technology
IVF 2.0 is a software company developing artificial intelligence tools for use in in vitro fertilisation laboratories. Its products apply computer vision and deep learning to microscopy imagery to provide quantitative assessments of embryo and sperm quality, supporting embryologists in selection decisions that are…
AI-driven antibody reagents and diagnostics for research and clinical use
Vertebrate Antibodies is a contract research organisation developing custom monoclonal antibodies, recombinant proteins, and AI-driven diagnostic products for research and clinical applications. Its AI-driven epitope prediction and antigen display platforms enable highly specific antibody generation against novel…